Flemish life-sciences startups continue to attract international capital as Belgium cements its health-tech reputation.
Ghent biotech cluster secures major Series C for cancer diagnostics
Flemish life-sciences startups continue to attract international capital as Belgium cements its health-tech reputation.
Read at source